Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 44.

Kusejko, K; Marzel, A; Hampel, B; Bachmann, N; Nguyen, H; Fehr, J; Braun, D L; Battegay, M; Bernasconi, E; Calmy, A; Cavassini, M; Hoffmann, M; Böni, J; Yerly, S; Klimkait, T; Perreau, M; Rauch, A; Günthard, H F; Kouyos, R D; Swiss HIV Cohort Study (2018). Quantifying the drivers of HIV transmission and prevention in men who have sex with men: a population model-based analysis in Switzerland. HIV Medicine, 19(10):688-697.

Hongler, J; Musaazi, J; Ledergerber, B; Eberhard, N; Sekaggya-Wiltshire, C; Keller, P M; Fehr, J; Castelnuovo, B (2018). Comparison of Löwenstein-Jensen and BACTEC MGIT 960 culture for Mycobacterium tuberculosis in people living with HIV. HIV Medicine, 19(9):654-661.

Becker, A S; Blüthgen, C; Phi van, V D; Sekaggya-Wiltshire, C; Castelnuovo, B; Kambugu, A; Fehr, J; Frauenfelder, T (2018). Detection of tuberculosis patterns in digital photographs of chest X-ray images using Deep Learning: feasibility study. The International Journal of Tuberculosis and Lung Disease, 22(3):328-335.

Salazar-Vizcaya, L; Kouyos, R D; Fehr, J; Braun, D; Estill, J; Bernasconi, E; Delaloye, J; Stöckle, M; Schmid, P; Rougemont, M; Wandeler, G; Günthard, H F; Keiser, O; Rauch, A; Swiss HIV Cohort Study (2018). On the potential of a short-term intensive intervention to interrupt HCV transmission in HIV-positive men who have sex with men: A mathematical modelling study. Journal of Viral Hepatitis, 25(1):10-18.

Hampel, Benjamin; Kusejko, K; Braun, D L; Harrison-Quintana, J; Kouyos, Roger; Fehr, J (2017). Assessing the need for a pre-exposure prophylaxis programme using the social media app Grindr®. HIV Medicine, 18(10):772-776.

Sekaggya-Wiltshire, C; von Braun, A; Scherrer, A U; Manabe, Y C; Buzibye, A; Muller, D; Ledergerber, B; Gutteck, U; Corti, N; Kambugu, A; Byakika-Kibwika, P; Lamorde, M; Castelnuovo, B; Fehr, J; Kamya, M R (2017). Anti-TB drug concentrations and drug-associated toxicities among TB/HIV-coinfected patients. Journal of Antimicrobial Chemotherapy, 72(4):1172-1177.

Helfenstein, M; Zweifel, S; Barthelmes, D; Meier, F; Fehr, J; Böni, C (2017). Ocular Toxoplasmosis: Therapy-Related Adverse Drug Reactions and Their Management. Klinische Monatsblätter für Augenheilkunde, 234(4):556-560.

Sekaggya-Wiltshire, C; von Braun, A; Lamorde, M; Ledergerber, B; Buzibye, A; Henning, L; Musaazi, J; Gutteck, U; Denti, P; De Kock, M; Alexander, J; Byakika-Kibwika, P; Eberhard, N; Matovu, J; Joloba, M; Muller, D; Manabe, Y; Kamya, M; Corti, N; Kambugu, A; Castelnuovo, B; Fehr, J (2017). Delayed sputum conversation in TB-HIV co-infected patients with low isoniazid and rifampicin concentrations. Clinical Infectious Diseases:Epub ahead of print.

Aebi-Popp, K; Kouyos, R; Bertisch, B; Staehelin, C; Rudin, C; Hoesli, I; Stoeckle, M; Bernasconi, E; Cavassini, M; Grawe, C; Lecompte, T D; Rickenbach, M; Thorne, C; Martinez de Tejada, B; Fehr, J (2016). Postnatal retention in HIV care: insight from the Swiss HIV Cohort Study over a 15-year observational period. HIV Medicine, 17(4):280-288.

Schaerer, V; Haubitz, S; Kovari, H; Ledergerber, B; Ambrosioni, J; Cavassini, M; Stoeckle, M; Schmid, P; Decosterd, L; Aouri, M; Böni, J; Günthard, H F; Furrer, H; Metzner, K J; Fehr, J; Rauch, A (2015). Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptake. HIV Medicine, 16(10):599-607.

von Braun, A; Sekaggya, C; Henning, L; Nakijoba, R; Kambugu, A; Fehr, J; Castelnuovo, B (2015). 'If at first you don't succeed, try again'. Looking beyond the initial results of a failed tuberculosis diagnosis. Public Health Action, 5(3):170-172.

Fehr, J; Nicca, D; Langewitz, W; Haerry, D; Battegay, M (2015). Assessing HIV-positive Persons’ Readiness to Start and Maintain ART. In: Ryom, L. EACS Guidelines. Brussels: EACS, 22-25.

Fehr, J. Cofactors influencing morbidity and mortality of human immunodeficiency virus infected individuals in the era of highly active antiretroviral therapy. 2015, University of Zurich, Faculty of Medicine.

Itin, P; Bosshard, P; Toutous-Trellu, L; Schmidt, A J; Vernazza, P; Tarr, P; Stoeckle, M; Wymann, M P; Ciardo, D; Walser, S; Claass, J; Scheidegger, C; Lowe, N; Oertle-Meyer, D; Cavassini, M; Schmid, P; Bernasconi, E; Haerry, D; Boffi-El Amari, E; Herold, M; Klimkait, T; Kahlert, C; Furrer, H J; Lautenschlager, S; Calmy, A; Fehr, J (2015). Syphilis: diagnostic and treatment. Swiss Medical Forum, 19:459-465.

Braun, D L; Rauch, A; Durisch, N; Eberhard, N; Anagnostopoulos, A; Ledergerber, B; Metzner, K J; Böni, J; Weber, R; Fehr, J (2014). Efficacy of lead-in silibinin and subsequent triple therapy in difficult-to-treat HIV/hepatitis C virus-coinfected patients. HIV Medicine, 15:625-630.

Braun, D l; Rauch, A; Durisch, N; Eberhard, N; Anagnostopoulos, A; Ledergerber, B; Metzner, K J; Böni, J; Weber, R; Fehr, J (2014). Efficacy of lead-in silibinin and subsequent triple therapy in difficult-to-treat HIV/hepatitis C virus-coinfected patients. Neurobehavioral HIV Medicine, 15(10):625-630.

Vadasz, V; Fehr, J; Gerth-Kahlert, C (2014). Gelbe Flecken und wie weiter? Der Ophthalmologe, 111(12):1213-1216.

Fehr, J; Nicca, D; Langewitz, W; Haerry, D; Battegay, M (2013). Assessing HIV-positive persons' readiness to start and maintain ART. In: European AIDS Clinical Society. Guidelines of the European AIDS Clinical Society. Paris/France: European AIDS Clinical Society, 6.

Preiswerk, B; Rudiger, A; Fehr, J; Corti, N (2013). Experience with daptomycin daily dosing in ICU patients undergoing continuous renal replacement therapy. Infection, 41(2):553-557.

Misselwitz, B; Bachli, E B; Kaiser, P; Fehr, J; Goede, J S (2012). Diagnosis of hypersplenism with the epinephrine stimulation test - 23 years of experience at a tertiary care hospital. Swiss Medical Weekly, 2012(141):w13324.

Clifford, G M; Lise, M; Franceschi, S; Egger, M; Bouchardy, C; Korol, D; Levi, F; Ess, S; Jundt, G; Wandeler, G; Fehr, J; Schmid, P; Battegay, M; Bernasconi, E; Cavassini, M; Calmy, A; Keiser, O; Schöni-Affolter, F (2012). Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. British Journal of Cancer, 106(3):447-452.

Lederer, H; Achermann, Y; Tinguely, M; Stenner, F; Fehr, J (2012). Multicentric Castleman's disease as a cause for unclear febrile episodes in a 55-year-old HIV-infected man. Infection, 40(2):203-205.

Fenner, L; Gagneux, S; Helbling, P; Battegay, M; Rieder, H L; Pfyffer, G E; Zwahlen, M; Furrer, H; Siegrist, H H; Fehr, J; Dolina, M; Calmy, A; Stucki, D; Jaton, K; Janssens, J P; Stalder, J M; Bodmer, T; Ninet, B; Böttger, E C; Egger, M (2012). Mycobacterium tuberculosis transmission in a country with low tuberculosis incidence: Role of immigration and HIV infection. Journal of Clinical Microbiology, 50(2):388-395.

Huber, M; Ledergerber, B; Sauter, R; Young, J; Fehr, J; Cusini, A; Battegay, M; Calmy, A; Orasch, C; Nicca, D; Bernasconi, E; Jaccard, R; Held, L; Weber, R (2012). Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians. HIV medicine, 13(7):387-397.

Schuepbach, R A; Bestmann, L; Bechir, M; Fehr, J; Bachli, E B (2011). High prevalence of iron deficiency among educated hospital employees in Switzerland. International Journal of Biomedical Science, 7(2):150-157.

Elzi, L; Steffen, I; Furrer, H; Fehr, J; Cavassini, M; Hirschel, B; Hoffmann, M; Bernasconi, E; Bassetti, S; Battegay, M (2011). Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB™) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-infection. BMC Infectious Diseases, 11:319.

Fehr, J; Glass, T R; Louvel, S; Hamy, F; Hirsch, H H; von Wyl, V; Böni, J; Yerly, S; Bürgisser, P; Cavassini, M; Fux, C A; Hirschel, B; Vernazza, P; Martinetti, G; Bernasconi, E; Günthard, H F; Battegay, M; Bucher, H C; Klimkait, T (2011). Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals--the Swiss HIV Cohort Study. Journal of Translational Medicine, 9:14.

Benz, R; Stüssi, G; Fehr, J (2010). Interferon as an alternative to purine analogues in the treatment of hairy cell leukaemia. British Journal of Haematology, 148(4):664-666.

Broz, P; Jacob, A L; Fehr, J; Kissel, C K (2010). An unusual presentation of amebic liver abscesses. Canadian Medical Association Journal (CMAJ), 182(16):1755-1757.

Benz, R; Siciliano, R D; Stussi, G; Fehr, J (2009). Long-term follow-up of interferon-alpha induction and low-dose maintenance therapy in hairy cell leukemia. European Journal of Haematology, 82(3):194-200.

Saxer, F; Widmer, A; Fehr, J; Soka, I; Kibatala, P; Urassa, H; Frei, R; Smith, T; Hatz, C (2009). Benefit of a single preoperative dose of antibiotics in a sub-saharan district hospital: minimal input, massive impact. Annals of Surgery, 249(2):322-326.

Fehr, J; Favrat, B; Schleiffenbaum, B; Krayenbühl, P A; Kapanci, C; Von Orelli, F (2009). Diagnose und Behandlung von Eisenmangel ohne Anämie. Praxis, 98(24):1445-1451.

Singer, T; Snozzi, R (2009). Empathie aus der Sicht der sozialen Neurowissenschaften. In: Fehr, J; Folkers, G. Gefühle zeigen: Manifestationsformen emotionaler Prozesse. Zürich, Switzerland: Chronos, 97-113.

Dang, T; Jaton-Ogay, K; Flepp, M; Kovari, H; Evison, J M; Fehr, J; Schmid, P; Boffi El Amari, E; Cavassini, M; Odorico, M; Tarr, P E; Greub, G (2009). High prevalence of anorectal chlamydial infection in HIV-infected men who have sex with men in Switzerland. Clinical Infectious Diseases, 49(10):1532-1535.

Bellini, C; Keiser, O; Chave, J P; Evison, Jm; Fehr, J; Kaiser, L; Weber, R; Vernazza, P; Bernasconi, E; Telenti, A; Cavassini, M (2009). Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study. HIV Medicine, 10(1):12-18.

Conen, A; Fehr, J; Glass, T R; Furrer, H; Weber, R; Vernazza, P; Hirschel, B; Cavassini, M; Bernasconi, E; Bucher, H C; Battegay, M (2009). Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study. Antiviral Therapy, 14(3):349-357.

Benz, R; Goede, J S; Parlier, V; Mühlematter, D; Jotterand, M; Fehr, J (2008). G-CSF-induced remission in two cases of acute myeloid leukemia. Leukemia Research, 32(7):1148-1152.

Gianella, S; Schaer, D J; Schwarz, U; Kurrer, M; Heppner, F L; Fehr, J; Seebach, J D (2008). Retinal microangiopathy and rapidly fatal cerebral edema in a patient with adult-onset Still's disease and concurrent macrophage activation syndrome. American Journal of Hematology, 83(5):424-427.

Hafner, J; Kühne, A; Bombeli, T; Schär, B; Hänseler, E; Lüthi, R; Hauser, M; Seifert, Burkhardt; Fehr, J (2006). Thrombophilie bei Patienten mit venösen Ulzera. Phlebologie, 35(6):289-293.

Hermann, D M; Fehr, J; Bassetti, C L (2005). Epstein Barr–virus (EBV) associated T–cell clonopathy mimicking lymphomatous meningitis. Journal of Neurology, 252(6):736-737.

Bombeli, T; Jutzi, M; De Conno, E; Seifert, Burkhardt; Fehr, J (2002). In patients with deepvein thrombosis elevated levels of factor VIII correlate only with von Willebrand factor but not other endothelial cell-derived coagulation and fibrinolysis proteins. Blood Coagulation & Fibrinolysis, 13(7):577-581.

Binder, D; van den Broek, M F; Kägi, D; Bluethmann, H; Fehr, J; Hengartner, H; Zinkernagel, R M (1998). Aplastic anemia rescued by exhaustion of cytokine-secreting CD8+ T cells in persistent infection with lymphocytic choriomeningitis virus. Journal of Experimental Medicine, 187(11):1903-1920.

Seebach, J D; Morant, R; Rüegg, R; Seifert, Burkhardt; Fehr, J (1997). The diagnostic value of the neutrophil left shift in predicting inflammatory and infectious disease. American Journal of Clinical Pathology, 107(5):582-591.

Fehr, J; Dahinden, C; Russi, R (1984). Formylated Chemotactic Peptides Can Mimic the Secondary, Provoking Endotoxin Injection in the Generalized Shwartzman Reaction. Journal of Infectious Diseases, 150(1):160-161.

This list was generated on Mon Feb 18 10:04:01 2019 CET.